(S1 (S (NP (NP (NN Disruption)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B) (NN signaling)) (CC and) (NP (NN chemokine) (NN gene) (NN activation)))) (PP (IN by) (NP (NP (JJ retroviral) (JJ mediated) (NN expression)) (PP (IN of) (NP (NN IKK) (NN gamma/NEMO) (NNS mutants))))) (. .))))
(S1 (S (S (NP (NP (NN Phosphorylation)) (PP (IN of) (NP (NP (NN I) (NN kappa) (NNS Bs)) (: --) (NP (NP (DT the) (JJ cytoplasmic) (NNS inhibitors)) (PP (IN of) (NP (DT the) (NP (NN NF-kappa) (NN B)) (NN transcription) (NNS factors)))) (: --)))) (VP (VBZ is) (NP (NP (DT the) (JJ key) (NN event)) (SBAR (WHNP (WDT which)) (S (VP (VBZ triggers) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN NF-kappa) (NN B) (NN cascade)))))))))) (. .)))
(S1 (S (S (NP (NP (JJ Signal-mediated) (NN phosphorylation)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha)))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NP (NP (DT a) (JJ multiprotein) (NN complex)) (, ,) (NP (DT the) (NP (NP (NN I) (NN kappa) (NN B) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN IKK)) (-RRB- -RRB-))) (NN complex)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN composed) (PP (IN of) (NP (QP (IN at) (JJS least) (CD three)) (VBN identified) (NNS subunits)))))))))))) (. .)))
(S1 (S (S (NP (NP (NP (CD Two)) (PP (IN of) (NP (DT these) (NNS polypeptides)))) (, ,) (NP (NP (NP (NN IKK) (NN alpha)) (CC and) (NP (NN IKK) (NN beta))) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (NP (NN IKK1)) (CC and) (NP (NN IKK2)))))) (, ,)) (VP (VP (VBP are) (NP (NP (DT the) (JJ catalytic) (NNS subunits)) (PP (IN of) (NP (DT the) (NN kinase) (NN complex))))) (CC and) (VP (VBP phosphorylate) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha)) (CC and) (NP (NN I) (NN kappa) (NN B) (NN beta)))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ third) (NN component)) (, ,) (NP (NN NEMO/IKK) (NN gamma)) (, ,)) (VP (VP (VBZ does) (RB not) (VP (VB exhibit) (NP (NN kinase) (NN activity)))) (, ,) (CC but) (ADVP (RB rather)) (VP (VBZ constitutes) (NP (DT a) (JJ regulatory) (NN subunit))))) (. .)))
(S1 (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (NP (NP (JJ C-terminal) (JJ truncated) (NNS forms)) (PP (IN of) (NP (NN IKK) (NN gamma)))) (: --) (NP (NP (NN Delta) (NN C-IKK) (NN gamma) (CD 306)) (CC and) (NP (NN Delta) (NN C-IKK) (NN gamma) (CD 261))) (: --)) (VP (VBD were) (ADVP (RB stably)) (VP (VBN expressed) (PP (IN in) (NP (DT the) (JJ myeloid) (NN cell) (NN line) (NN U937))) (PP (IN by) (NP (JJ retroviral-mediated) (NN gene) (NN transfer)))))) (. .)))
(S1 (S (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN Delta) (NN C-IKK) (NN gamma)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NN IKK) (NN kinase) (NN activity))) (ADVP (FW in) (FW vitro))) (, ,) (NP (NP (DT a) (JJ subsequent) (NN decrease)) (PP (IN in) (NP (NP (NN NF-kappa) (NN B)) (NN DNA) (NN binding) (NN activity)))) (, ,) (CC and) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NN chemokine) (NN gene) (NN induction)) (PP (IN in) (NP (NP (NP (NN response)) (PP (TO to) (NP (NN TNFalpha) (NN stimulation)))) (CC or) (NP (NN paramyxovirus) (NN infection))))))))))) (. .)))
(S1 (S (S (NP (DT This) (NN study)) (VP (VP (VBZ demonstrates) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (NN Delta) (NN C-IKK) (NN gamma)))) (PP (IN as) (NP (NP (DT a) (NN repressor)) (PP (IN of) (NP (NP (NN IKK) (NN signaling)) (CC and) (NP (NP (NN NF-kappa) (NN B)) (NN activation))))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (NP (JJ potential) (NN gene) (NN therapy)) (NN approach)) (S (VP (TO to) (VP (VB limit) (NP (JJ chronic) (NN inflammation)) (PP (JJ due) (TO to) (NP (NN chemokine) (NN hyperactivation)))))))))) (. .)))
